6 үр дүн
FIELD OF THE INVENTION
The present invention relates to chimeric fibroblast growth factor ("FGF") proteins and uses thereof.
BACKGROUND OF THE INVENTION
Type 2 diabetes is a chronic progressive disorder, which results from end-organ resistance to the action of insulin in combination with
FIELD OF THE INVENTION
The present invention relates to chimeric fibroblast growth factor ("FGF") proteins and uses thereof.
BACKGROUND OF THE INVENTION
Type 2 diabetes is a chronic progressive disorder, which results from end-organ resistance to the action of insulin in combination with
FIELD OF THE INVENTION
The present invention relates to chimeric fibroblast growth factor ("FGF") proteins and uses thereof.
BACKGROUND OF THE INVENTION
Type 2 diabetes is a chronic progressive disorder, which results from end-organ resistance to the action of insulin in combination with
FIELD OF THE INVENTION
The present invention relates to chimeric fibroblast growth factor ("FGF") proteins and uses thereof.
BACKGROUND OF THE INVENTION
Type 2 diabetes is a chronic progressive disorder, which results from end-organ resistance to the action of insulin in combination with
FIELD OF THE INVENTION
The present invention relates to chimeric fibroblast growth factor ("FGF") proteins and uses thereof.
BACKGROUND OF THE INVENTION
Type 2 diabetes is a chronic progressive disorder, which results from end-organ resistance to the action of insulin in combination with
TECHNICAL FIELD
The present invention relates to an adipogenesis inhibitory factor (ADIF) which is a novel protein having an activity of suppressing differentiation and/or maturation of adipocytes, and to methods for producing the same.
The protein of the present invention is useful as a